Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Belimumab With Rituximab for Primary Membranous Nephropathy

ClinicalTrials.gov ID: NCT03949855

Public ClinicalTrials.gov record NCT03949855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 20, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (ITN080AI)

Study identification

NCT ID
NCT03949855
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
58 participants

Conditions and interventions

Interventions

  • Belimumab Drug
  • Placebo for Belimumab Drug
  • Rituximab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2020
Primary completion
Feb 28, 2029
Completion
Feb 28, 2030
Last update posted
May 18, 2026

2020 – 2030

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham School of Medicine: Division of Nephrology Birmingham Alabama 35294 Recruiting
University of Arkansas Little Rock Arkansas 72205 Recruiting
University of California San Francisco San Francisco California 94146 Recruiting
Stanford University School of Medicine: Division of Nephrology Stanford California 94305 Recruiting
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension Torrance California 90502 Recruiting
University of Colorado Aurora Colorado 80045 Recruiting
Mayo Clinic Jacksonville: Department of Nephrology and Hypertension Jacksonville Florida 32224 Recruiting
University of Miami Miller School of Medicine, Div of Nephrology Miami Florida 33136 Recruiting
Johns Hopkins Baltimore Maryland 21287 Recruiting
National Institutes of Health Clinical Center Bethesda Maryland 20892 Recruiting
University of Michigan Ann Arbor Michigan 48104 Recruiting
University of Minnesota Health Clinical Research Unit Minneapolis Minnesota 55455 Recruiting
Washington University in St. Louis St Louis Missouri 63110 Recruiting
University of Nebraska Omaha Nebraska 68198 Recruiting
Columbia University Medical Center: Division of Nephrology New York New York 10032 Recruiting
University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center Chapel Hill North Carolina 27599- Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Ohio State University Wexner Medical Center: Division of Nephrology Columbus Ohio 43210 Recruiting
University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division Philadelphia Pennsylvania 19104 Recruiting
Providence Medical Research Center, Providence Health Care: Nephrology Spokane Washington 99204 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03949855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03949855 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →